| Opportunity Village | |
|
1200 N 9th St W Clear Lake IA 50428-1100 | |
| (641) 357-5277 | |
| Not Available |
| Full Name | Opportunity Village |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 1200 N 9th St W, Clear Lake, Iowa |
| Authorized Official Name and Position | Jim Aberg (SERVICES DIRECTOR) |
| Authorized Official Contact | 6413551285 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Opportunity Village 1200 N 9th St W Po Box 622 Clear Lake IA 50428-1100 Ph: (641) 357-5277 | Opportunity Village 1200 N 9th St W Clear Lake IA 50428-1100 Ph: (641) 357-5277 |
| NPI Number | 1619337706 |
|---|---|
| Provider Enumeration Date | 03/02/2016 |
| Last Update Date | 03/02/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619337706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
Scientists have reported in the journal Genome Research that they have successfully cloned and characterized a previously intractable DNA sequence: a 554-kilobase-pair genomic segment near the centromere of the human Y chromosome. This sequence contains eight putatively active genes that could be implicated in sex-associated height differences and gonadal tumor development.
TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, will present the first analyses of results from its AIGISRx Anti-Bacterial Envelope Retrospective Registry during the Transcatheter Cardiovascular Therapeutics (TCT 2009) meeting in San Francisco, CA.
The active ingredient in many insect repellents, deet, has been found to be toxic to the central nervous system. Researchers writing in the open access journal BMC Biology say that more investigations are urgently needed to confirm or dismiss any potential neurotoxicity to humans, especially when deet-based repellents are used in combination with other neurotoxic insecticides.
Omeros Corporation announced that OMS824, its phosphodiesterase 10 inhibitor, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Huntington's disease.
› Verified 2 days ago
Opportunity Village Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N 9th St W, Clear Lake, IA 50428 Phone: 641-357-5277 Fax: 641-357-6491 | |
Opportunity Village Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N 9th St W, Clear Lake, IA 50428 Phone: 641-357-5277 Fax: 641-357-6491 | |
Opportunity Village Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N 9th St W, Clear Lake, IA 50428 Phone: 641-357-5277 | |
Opportunity Village Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N 9th St W, Clear Lake, IA 50428 Phone: 641-357-5277 Fax: 641-357-6491 | |
Opportunity Village Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N 9th St W, Clear Lake, IA 50428 Phone: 641-357-5277 | |
Opportunity Village Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N 9th St W, Clear Lake, IA 50428 Phone: 641-357-5277 Fax: 641-357-6491 | |
Opportunity Village Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 N 9th St W, Clear Lake, IA 50428 Phone: 641-357-5277 |